Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

LIF3010 Leukemia Inhibitory Factor Protein, Recombinant rat

LIF3010
10 µg  
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Tabella delle specifiche principali

Key ApplicationsSpeciesSourcePurity
Cult, CULTRat rtLIF is expressed in E. coli as a fusion protein with GST using the pGEX expression system, cleaved from GST moiety with thrombin and purified by ion-exchange chromatography.Greater than 85% by analytical HPLC and SDS-PAGE. Endotoxin level is less than 0.1 ng per μg of LIF. Tested negative in both aseptic and mycoplasma tests.
Description
Catalogue NumberLIF3010
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionLeukemia Inhibitory Factor Protein, Recombinant rat
OverviewRat LIF (rtLIF) is a 22.1 kDa protein containing 202 amino acid residues that exhibits 91% amino acid sequence identity with murine LIF(Takahama etal 1998).Analysis of the secondary structure of rat and murine LIF indicates a difference in the two dimensional structure of both proteins. Studies have shown that rtLIF is more effective in maintaining the undifferentiated phenotype of rat ES cells than similar concentrations of murine LIF (Takahama, et al 1998).
Alternate Names
  • LIF
Background InformationLeukemia Inhibitory Factor (LIF) is a lymphoid factor which promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo.
References
Product Information
HS Code3002 15 90
PresentationLiquid in 50mM sodium phosphate/1mM DTT / 10% glycerol / 250mM NaCl, pH 7.4 and 0.02% Tween 20. No preservativies added.
Quality LevelMQ300
Applications
ApplicationRecombinant rat Leukemia Inhibitory Factor (LIF) protein is biologically active and suitable for cell culture applications.
Key Applications
  • Stem Cell Culture
  • Cell Culture
Application NotesRECOMMENDED QC PROTOCOL

M1 Bioassay

1.The M1 bioassay is performed using in vitro semi-solid agar cultures, which contain approximately 100 cells in 1 mL volumes of DME containing 20 % FCS in 0.3% agar.

2.Add 100 μL of sample or rtLIF (10(e4) units/mL in 5% FCS in isotonic saline) in two-fold serial dilutions in duplicate to 35 mm petri dishes.

3.Add 100 μL of 5% FCS in isotonic saline to two control slides.

4.Incubate at 37°C in fully humidified atmosphere of 10% CO2 in air for 7 days.

5.Score the number of colonies that show differentiation (note: 50 units is defined as the amount of activity which results in 50% of the colonies being differentiated).

Visit www.esgro-lif.com for additional information
Biological Information
Concentration10 μg/mL
PurityGreater than 85% by analytical HPLC and SDS-PAGE. Endotoxin level is less than 0.1 ng per μg of LIF. Tested negative in both aseptic and mycoplasma tests.
SourcertLIF is expressed in E. coli as a fusion protein with GST using the pGEX expression system, cleaved from GST moiety with thrombin and purified by ion-exchange chromatography.
Specific ActivityThe activity of rat LIF is determined by the ability to induce differentiation of M1 myeloid leukemic cells. The minimum detectable concentration of rat LIF in this assay is 0.5 ng/mL. The specific activity is >=1 x 10(e8) units/mg, where 50 units is defined as the amount of rat LIF required to induce differentiation in 50% of the M1 colonies in 1 mL agar cultures.
Entrez Gene SummaryLeukaemia inhibitory factor is a cytokine that induces macrophage differentiation. Neurotransmitters and neuropeptides, well known for their role in the communication between neurons, are also capable of activating monocytes and macrophages and inducing chemotaxis in immune cells. LIF signals through different receptors and transcription factors. LIF in conjunction with BMP2 acts in synergy on primary fetal neural progenitor cells to induce astrocytes.
Gene Symbol
  • NM_022196
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P17777 # LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.
SIZE: 202 amino acids; 22113 Da
SUBCELLULAR LOCATION: Secreted.
SIMILARITY: SwissProt: P17777 ## Belongs to the LIF/OSM family.
Stem Cell Type
  • Mouse Embryonic Stem Cells
  • Neural Stem Cells
  • Hematopoietic Stem Cells
  • Mesenchymal Stem Cells
  • Induced Pluripotent Stem Cells
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsRat LIF is shipped on dry ice. Maintain at -20°C until expiration date. Further dilutions should be made into buffer or medium to which protein (e.g., 1% BSA) or Tween 20 has been added and stored at -20°C. Freeze thawing is not recommended.
Packaging Information
Material Size10 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
LIF3010 04053252270017

Documentation

Leukemia Inhibitory Factor Protein, Recombinant rat MSDS

Titolo

Scheda di sicurezza (MSDS) 

Leukemia Inhibitory Factor Protein, Recombinant rat Certificati d'Analisi

TitoloNumero di lotto
PURE RAT LIF (10g) - ME9EN7802 ME9EN7802
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) 3015436
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) 2755903A
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 1797303B 1797303B
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 1798763C 1798763C
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 1798763D 1798763D
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 2029660 2029660
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 3015436A 3015436A
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 3318783 3318783
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF) - 3744152 3744152

Riferimenti bibliografici

Panoramica dei riferimenti bibliograficiCodice d'identificazione nel Pub Med
Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism.
Florholmen, G, et al.
Acta Physiol. Scand., 180: 133-42 (2004)  2004

Mostra il sommario
14738472 14738472

Scheda tecnica

Titolo
RECOMBINANT RAT LEUKEMIA INHIBITORY FACTOR (rtLIF)

Prodotti e applicazioni correlate

Linee di prodotti

Categorie

Life Science Research > Proteins and Enzymes > Cytokines & Growth Factors
Life Science Research > Cell Culture and Systems > Cell Culture Media and Supplements > Cell Culture Supplements > Cytokines & Growth Factors